drugset / Trial / NCT07057011

Therapeutic Outcomes of Selective Serotonin Reuptake Inhibitors and Phosphodiesterase-5 Inhibitors Combination Therapy Versus Monotherapy

NCT07057011

Not yet recruiting 60 enrolled South Valley University
RandomizedParallel-groupOpen-labelTreatment

Summary

Premature ejaculation (PE) is a prevalent male sexual dysfunction that affects as many as 20-30% of men regardless of age and ethnicity.The International Society for Sexual Medicine defines premature ejaculation as a male sexual dysfunction characterised by ejaculation that always or nearly always occurs before or within about 1 minute of vaginal penetration from the first sexual experience (lifelong premature ejaculation) or a clinically significant and bothersome reduction in latency time, often to about 3 minutes or less (acquired premature ejaculation), the inability to delay ejaculation on all or nearly all vaginal penetrations and with negative personal consequences include distress, bother, frustration, and avoidance of sexual intimacy.

Timeline

Start
2025-07-01
Primary completion
2026-02-01
Completion
2026-02-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator Paroxetine Small molecule 20 mg Oral
Comparator Sildenafil Unknown 25 mg Oral

Indications